Parkinson’s disease has long been understood as a disorder rooted in the brain, driven by the loss of dopamine‑producing neurons and the accumulation of misfolded proteins. However, new research highlighted by ScienceAlert challenges this traditional view. The study suggests that Parkinson’s may actually begin in an unexpected organ: the kidneys. This finding expands the growing scientific conversation about whether the disease originates outside the brain and only later spreads into the nervous system.

 

The research focuses on alpha‑synuclein (α‑Syn), a protein strongly associated with Parkinson’s disease. When α‑Syn misfolds and clumps together, it forms toxic aggregates that interfere with brain function. According to the article, the key discovery is that “α‑Syn clumps can build up in the kidneys, as well as the brain”. This challenges the long‑held assumption that the earliest pathological changes occur exclusively in the central nervous system. Instead, the kidneys may serve as an early reservoir where harmful protein structures begin to accumulate before they appear in the brain.

 

This idea is significant because it reframes how scientists think about the disease’s progression. Parkinson’s is typically diagnosed only after motor symptoms—such as tremors, stiffness, and slowed movement—become noticeable. By that point, substantial neuronal damage has already occurred. If α‑Syn pathology begins in the kidneys, it may mean that the disease is silently developing long before neurological symptoms appear. This opens the possibility of detecting Parkinson’s earlier through kidney‑related biomarkers or imaging techniques.

 

The study also raises important questions about how α‑Syn might travel from the kidneys to the brain. One possibility is that misfolded proteins spread through the bloodstream or peripheral nerves, gradually reaching the central nervous system. This would align with other emerging theories suggesting that Parkinson’s may begin in the gut or the nose before spreading inward. The ScienceAlert article emphasizes that the kidneys “may play a larger role in Parkinson’s disease than we thought”, underscoring the need to broaden the search for the disease’s origins beyond the brain.

 

If confirmed, these findings could reshape treatment strategies. Instead of focusing solely on protecting neurons or clearing protein aggregates from the brain, future therapies might aim to prevent α‑Syn misfolding in peripheral organs. This could involve targeting kidney function, reducing systemic inflammation, or developing drugs that block the earliest stages of protein aggregation. Such an approach would represent a major shift toward early intervention and prevention, rather than attempting to reverse damage after it has already occurred.

 

While the research is still in its early stages, it contributes to a growing body of evidence that Parkinson’s is a multi‑organ disease, not just a neurological one. By identifying the kidneys as a potential starting point, the study encourages scientists to rethink long‑standing assumptions and explore new pathways for diagnosis and treatment. As the understanding of Parkinson’s continues to evolve, this work highlights the importance of looking beyond the brain to uncover the full story of how the disease begins and spreads.

 

Note: This page summarizes research findings published in Science Daily (2025). Readers interested in detailed methodologies and complete data should consult the original research article: Nield, D. “Parkinson’s Disease Might Not Start in the Brain, Study Finds.” ScienceAlert. https://www.sciencealert.com/parkinsons-disease-might-not-start-in-the-brain-study-finds

​